EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
β Scribed by Bhargava, Rohit; Gerald, William L; Li, Allan R; Pan, Qiulu; Lal, Priti; Ladanyi, Marc; Chen, Beiyun
- Book ID
- 109888269
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 258 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0893-3952
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background and Objectives In this paper we examined the influence of epidermal growth factor receptor (EGFR) gene mutations on EGFR expression, downstream mediators, and survival in patients with nonβsmall cell lung cancer (NSCLC). ## Methods We retrospectively analyzed the tumors
## Abstract ## BACKGROUND. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFRβTKIs) have demonstrated clinical benefit in patients with nonsmall cell lung cancer (NSCLC), particularly those with tumors that have EGFRβTK domain mutations. Moreover, the EGFR and cyclooxygenase (COX)β2